Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases
International Journal of Nanomedicine · 2025-12 · Volume 20 · 14667-14694
DOI: 10.2147/ijn.s562666 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025-12. Verfasst von Xiaolan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School…. Hauptthemen laut MEDLINE: Mitochondria, Central Nervous System Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Mitochondrial dysfunction represents a pivotal pathological mechanism underlying diverse diseases, particularly those affecting the central nervous system (CNS). Consequently, therapeutic strategies capable of effectively restoring mitochondrial function hold significant promise for treating CNS disorders. Nanotechnology has emerged as a powerful platform in this endeavor, leveraging the modifiability, controllability, and targeting capabilities of nanosystems to intervene at the mitochondrial level. This review delineates the critical role of mitochondrial integrity in CNS pathophysiology and summarizes key mitochondria-targeting strategies, including small-molecule ligands, mitochondrial-penetrating peptides, mitochondrial membrane-derived vesicles, and biomimetic membrane coatings. We also discuss the efficacy of mitochondria-targeted nanosystems in rescuing mitochondrial dysfunction across major CNS conditions, exemplified by neurodegenerative diseases, brain tumors, ischemic stroke, and traumatic brain injury. Ultimately, this review also points out current translational challenges and future research directions pivotal for advancing mitochondrial nanomedicine. Collectively, this work synthesizes progress in mitochondrial nanotherapeutics, highlighting their transformative potential while outlining critical barriers and opportunities for clinical translation in CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, First Affiliated Hospital of Zhejiang Chi…
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, People's Republic of China.
ORCID-Profile: Yanrong Zheng
Zitieren
APA
Zhang, X., Chen, J., Wan, B., Zheng, Y., & Chen, X. (2025). Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases. International Journal of Nanomedicine, Volume 20, 14667-14694. https://doi.org/10.2147/ijn.s562666
Vancouver
Zhang X, Chen J, Wan B, Zheng Y, Chen X. Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases. International Journal of Nanomedicine. 2025;Volume 20:14667-14694. doi:10.2147/ijn.s562666
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaolan and Chen, Jiahui and Wan, Bingjie and Zheng, Yanrong and Chen, Xiaojie},
title = {Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {14667--14694},
doi = {10.2147/ijn.s562666}
}
EUVIMED